38 results on '"Sueta, Carla"'
Search Results
2. CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy
3. OPTIMAL MEDICAL THERAPY USE AND LONG-TERM OUTCOMES IN CABG-ELIGIBLE HEART FAILURE PATIENTS: INSIGHTS FROM THE STICH TRIAL
4. Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study)
5. OUTCOMES OF WEEKEND VERSUS WEEKDAY ADMISSION FOR ACUTE DECOMPENSATED HEART FAILURE IN PATIENTS WITH REDUCED EJECTION FRACTION: THE ATHEROSCLEROSIS RISK IN COMMUNITIES SURVEILLANCE STUDY
6. READMISSIONS FOR PATIENTS DISCHARGED WITH ACUTE DECOMPENSATED HEART FAILURE AND REDUCED VERSUS PRESERVED EJECTION FRACTION: THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY
7. Influence of Neurohormonal Antagonists on the Association of Loop Diuretic Dose with Mortality in Patients with Heart Failure: Insights From the UNITE-HF Registry
8. Reactive hyperemia is associated with adverse clinical outcomes in heart failure
9. MORTALITY FOLLOWING INITIATION OR DISCONTINUATION OF GUIDELINE DIRECTED MEDICAL THERAPIES IN HOSPITALIZED HEART FAILURE PATIENTS IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY
10. VALIDATION OF THE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) POOLED COHORT RISK EQUATIONS BY EDUCATION LEVEL: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY
11. PROGNOSTIC IMPORTANCE OF SELF-REPORTED DYSPNEA FOR CARDIOVASCULAR OUTCOMES IN PERSONS WITHOUT PREVALENT CARDIOVASCULAR OR PULMONARY DISEASE: THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY
12. Medication Adherence Based on Part D Claims for Patients With Heart Failure After Hospitalization (from the Atherosclerosis Risk in Communities Study)
13. Anger Proneness, Gender, and the Risk of Heart Failure
14. Polypharmacy in Heart Failure
15. The STICH Trial (Surgical Treatment for Ischemic Heart Failure)
16. BETA-1 ADRENERGIC RECEPTOR GENOTYPE SER49GLY IS ASSOCIATED WITH BETA-BLOCKER SURVIVAL BENEFIT IN PATIENTS WITH HEART FAILURE
17. Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: Results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project
18. Managed Care Patients With Heart Failure: Spectrum of Ventricular Dysfunction and Predictors of Medication Utilization
19. Home-based exercise improves functional performance and quality of life in women with diastolic heart failure
20. Quality of heart failure care in managed Medicare and Medicaid patients in North Carolina**The analyses upon which this publication is based were performed under Contract 500-02-NC03, entitled “Utilization and Quality Control Peer Review Organization for the State of North Carolina,” sponsored by the Centers for Medicare & Medicaid Services, Department of Health and Human Services. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The investigator assumes full responsibility for the accuracy and completeness of the ideas presented. This article is a direct result of the Health Care Quality Improvement Program initiated by the Centers for Medicare & Medicaid Services, which has encouraged identification of quality improvement projects derived from analysis of patterns of care, and therefore required no special funding on the part of this contractor. Ideas and contributions to the investigator concerning experience in engaging with issues presented are welcomed.
21. Impaired renal function is common in outpatients with heart failure: results from the STAMINA-HFP (study of anemia in a heart failure population) registry
22. Low to moderate intensity home-based exercise improves exercise tolerance and quality of life in women with diastolic heart failure
23. Heart rate variability in chronic heart failure: target for therapy?
24. Survival rates are similar between African American and white patients with heart failure
25. Predictors of β-blocker utilization in managed care patients with heart failure
26. Utilization of ACE-1 and β-blocker therapy in managed care patients with heart failure: NC ACE project
27. Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure
28. Effect of angiotensin-converting inhibitor or angiotensin receptor blocker on one-year survival in patients ≥65 years hospitalized with a left ventricular ejection fraction ≥50%**The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. The investigator assumes full responsibility for the accuracy and completeness of the ideas presented. This study is a direct result of the Health Care Quality Improvement Program initiated by the Centers for Medicare & Medicaid Services, which has encouraged identification of quality improvement projects derived from analysis of patterns of care, and therefore required no special funding on the part of this contractor. Ideas and contributions to the investigator concerning experience in engaging with issues presented are welcomed.
29. Lipid management among coronary artery disease patients with diabetes mellitus or advanced age
30. Effect of angiotensin-converting enzyme inhibitor therapy on 30-day outcome in patients ≥65 years of age with chronic congestive heart failure∗∗The analyses upon which this publication is based were performed under contract number 500-96-P613, entitled “Operation of Utilization and Quality Control Peer Review Organization (PRO) for the state of North Carolina, sponsored by the Health Care Financing Administration, Department of Health and Human Services.” The conclusions and opinions expressed, and methods used herein are those of the investigators. They do not necessarily reflect Health Care Financing Administration policy. The investigators assume full responsibility for the accuracy and completeness of the ideas presented.
31. Association of body mass, gender and race with heart failure primarily due to hypertension
32. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease
33. Improving Care for Unstable Angina Patients in a Multiple Hospital Project Sponsored by a Federally Designated Quality Improvement Organization
34. Performance Assessment Model for Guideline-Recommended Pharmacotherapy in the Secondary Prevention of Coronary Artery Disease and Treatment of Left Ventricular Dysfunction
35. Relation Between Gender, Etiology and Survival in Patients With Symptomatic Heart Failure
36. Safety and efficacy of epoprostenol in patients with severe congestive heart failure
37. Acute hemodynamic effects of the prostacyclin analog 15AU81 in severe congestive heart failure
38. A microcirculatory technique for evaluating intravascular and topical administration of vasoactive agents: Response to AVP in the SHR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.